Ljubljana, Slovenia

Peter Venturini


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peter Venturini: Innovator in Pharmaceutical Formulations

Introduction

Peter Venturini is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical formulations, particularly in the stabilization of active substances. His innovative approach addresses the challenges associated with substances that are sensitive to acidic environments, moisture, and heat.

Latest Patents

Peter Venturini holds 1 patent for a pharmaceutical formulation with controlled release of active substances. This patent discloses a method for stabilizing active substances that are unstable in acidic mediums and when stored for extended periods in the presence of water. The method involves anhydrous granulation of active substances along with dried pharmaceutically acceptable auxiliary substances to create pellet cores or granules. The process ensures that all auxiliary substances are dried to minimize weight loss, and the organic solvents used contain less than 0.2% water.

Career Highlights

Venturini is associated with Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.d., a prominent pharmaceutical company. His work focuses on developing innovative solutions that enhance the stability and efficacy of pharmaceutical products. His contributions have been instrumental in advancing the field of drug formulation.

Collaborations

Peter has collaborated with notable colleagues, including Bojan Kofler and Ljubomira Barbara Rebi{haeck Over (c)}. These collaborations have fostered a productive environment for innovation and research in pharmaceutical sciences.

Conclusion

Peter Venturini's work in pharmaceutical formulations exemplifies the importance of innovation in the medical field. His patented methods for stabilizing active substances contribute significantly to the development of effective and reliable medications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…